Clinicopathologic Conference, Systemic Primary Amyloidosis
NEJM 384:363-372, Case 3-2021, 2021
Conversion of Amyloid Positive and Negative MCI to AD over 3 Years: An 11C-PIB PET Study
Neurol 73:754-760, 744, Okello,A.,et al, 2009
Pittsburg Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease
Arch Neurol 66:1469-1475, Morris,J.,et al, 2009
Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
Arch Neurol 65:1509-1517, Aizenstein,H.J.,et al, 2008
Amyloidosis Causing A Progressive Myopathy
Muscle & Nerve 18:1016-1018995., Nadkarni,N.,et al, 1995
Amyloidoma of the CNS. I. Clinical and Pathologic Study
Neurol 42:2019-2023, Cohen,M.,et al, 1992
Molecular Genetics of Amyloid Neuropathy in Europe
Lancet 1:524-526, Holt,I.J.,et al, 1989
Computed Tomographic Features of Nonthyroid Extraocular Muscle Enlargement
Ophthalmol 96:1038-1047, Patrinely,J.R.,et al, 1989